For: | Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275 [PMID: 34366604 DOI: 10.3748/wjg.v27.i27.4252] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v27/i27/4252.htm |
Number | Citing Articles |
1 |
Wen‐Qiang Wang, Guang‐Yuan Xu, Jian Li, Bin‐Yong Liang, Jiang Li, Mei‐Long Lin, Xiao‐Ping Chen, Er‐Lei Zhang, Zhi‐Yong Huang. HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma. Cancer Medicine 2023; 12(8): 9627 doi: 10.1002/cam4.5740
|
2 |
Ruofan Sheng, Heqing Wang, Yunfei Zhang, Wei Sun, Kaipu Jin, Yongming Dai, Weiguo Zhang, Mengsu Zeng, Jianjun Zhou. MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study. Journal of Magnetic Resonance Imaging 2024; 59(3): 1093 doi: 10.1002/jmri.28855
|
3 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 291 doi: 10.1002/9781119756422.ch17
|
4 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21): 13612 doi: 10.3390/ijms232113612
|